Milia—commonly referred to as "milk spots"—are tiny, pearly white to pale yellow, dome-shaped papules that develop primarily on facial skin. Most frequently observed around the delicate periocular skin, eyelids, cheeks, nose, and forehead, milia affect individuals across all age groups, from newborns to older adults.
Although milia superficially resemble whiteheads or closed comedones, they are fundamentally distinct in both structure and histopathology. Milia are small, benign epidermal keratin cysts trapped beneath an intact layer of stratum corneum without any follicular pore opening (ostium). Attempting to squeeze, pick, or pop a milium like an acne pimple is physically impossible and dermatologically dangerous—resulting in dermal tearing, secondary bacterial infection, permanent pitted scarring, or post-inflammatory hyperpigmentation (PIH).
Understanding the cellular origin of milia enables patients and operators to select safe, evidence-based management strategies—ranging from gentle at-home topical cell-turnover agents to single-visit in-office sterile de-roofing procedures.
At a Glance: Key Clinical & Evidence Summary
- Anatomical Structure: Milia are subepidermal retention cysts containing compacted, concentric layers of stratified keratin. They lack a natural pore opening, rendering manual squeezing ineffective and harmful.
- Neonatal Milia (40–50% Incidence): Extremely common congenital primary cysts appearing on the nose, cheeks, and oral mucosa (Epstein pearls and Bohn nodules) of healthy full-term newborns. They represent immature hair follicle structures, resolve spontaneously within weeks, and must never be treated.
- Primary vs. Secondary Subtypes: Primary adult milia arise spontaneously from the lower infundibular sebaceous collar of vellus hair follicles. Secondary (acquired) milia derive from damaged eccrine sweat ducts following skin trauma, burns, laser resurfacing, or heavy occlusive product use.
- Clinical Removal Standards: In-office sterile "de-roofing"—nicking the cyst wall with a sterile 25G/30G needle and expressing the intact keratin pearl—clears lesions immediately in a single visit with negligible scar risk.
- Topical Skincare & Prevention: OTC adapalene (Differin), prescription tretinoin, and exfoliating hydroxy acids (salicylic, glycolic) accelerate epidermal turnover, thinning the overlying skin roof to aid gradual exfoliation over 4 to 8 weeks.
- Financial & Insurance Status: Classified as a cosmetic concern by health plans; out-of-pocket extraction costs range from $100 to $300 per visit.
Cellular Biology & Epidermal Keratinization
To understand milia formation, one must examine the normal process of epidermal desquamation. Keratinocytes generated in the basal layer (stratum basale) differentiate as they migrate upward through the spinous and granular layers, eventually producing specialized structural proteins (cytokeratins K1 and K10) and envelope lipids. In healthy skin, mature corneocytes undergo programmed enzymatic cleavage of intercellular desmosomes (mediated by kallikrein-related peptidases), shedding imperceptibly from the skin surface.
EPIDERMAL DESQUAMATION vs. MILIUM CYST FORMATION
[Normal Epidermal Desquamation] [Milium Retention Cyst]
+-------------------------------+ +-------------------------------+
| Stratum Corneum (Desmosomes | | Intact Stratum Corneum Roof |
| cleaved by Kallikreins -> Shed)| | |
+-------------------------------+ | ________________________ |
| Granular & Spinous Layers | | / Keratin Pearl Capsule \ |
| | | | (Compacted Laminated K1/K10) |
| Basal Layer Keratinocytes | | \________________________/ |
+-------------------------------+ +-------------------------------+
When follicular keratinocytes fail to desquamate correctly within the vellus infundibulum or damaged eccrine duct, microscopic keratin flakes become trapped. As keratinocytes continue to shed into the enclosed space, they form a spherical, onion-skin-like pearl of densely compacted structural protein encapsulated by a true epithelium.
Histology & Differential Diagnosis: Why Popping Fails
Histologically, a milium consists of a true epidermoid cyst lined by a wall of stratified squamous epithelium with a granular layer. The central cavity is packed with tightly coiled, onion-skin layers of acellular keratin protein.
WHITEHEAD (Closed Comedone) vs. MILIUM (Keratin Cyst)
[Closed Comedone / Whitehead] [Milium / Keratin Cyst]
+-------------------------------+ +-------------------------------+
| Epidermis with Pore Opening | | Intact Epidermis (NO Pore) |
| || | | ________________________ |
| [Sebum + Bacteria] | | / Keratin Pearl Capsule \ |
| (Pliable Contents) | | | (Solid Compacted Keratin) | |
| | | \________________________/ |
+-------------------------------+ +-------------------------------+
Because there is no follicular ostium connecting the cyst cavity to the skin surface, applying lateral pressure pushes the solid keratin pearl deeper against dermal pain receptors and tears surrounding dermal collagen fibers.
Histologic Differentiation from Vellus Hair Cysts & Steatocystoma
In complex clinical evaluations, milia must be distinguished from other small follicular and sebaceous cysts that present on the face and neck:
- Eruptive Vellus Hair Cysts (EVHC): Histologically contain multiple vellus hair shafts embedded in a keratinaceous matrix lined by a stratified squamous epithelium without a granular layer.
- Steatocystoma Multiplex: True sebaceous duct cysts lined by a characteristic folded, eosinophilic, wavy cuticle lacking a granular layer, with flattened sebaceous lobules within or adjacent to the cyst wall.
- Epidermoid Cysts: Larger dermal cysts possessing an identical stratified squamous epithelial lining with a granular layer, but reaching 5 to 20+ mm in size with foul-smelling keratin breakdown contents.
Clinical Differential Matrix
Facial skin hosts several small, raised bumps that can be confused with milia. The table below outlines key features separating milia from common differential diagnoses:
| Condition | Histologic / Anatomical Origin | Typical Appearance | Key Diagnostic Features | Primary Management |
|---|---|---|---|---|
| Milium | Keratin retention cyst in vellus infundibulum or eccrine duct | 1–2 mm hard, pearly white/yellow papule; non-tender | Intact surface; no central pore; firm texture | Sterile in-office de-roofing; topical retinoids |
| Closed Comedone | Follicular infundibulum plugged with sebum and keratin | 1–3 mm soft white/flesh papule | Microscopic central ostium; compressible; responsive to BHA | Salicylic acid; benzoyl peroxide; comedone extraction |
| Syringoma | Benign eccrine sweat duct adenoma in upper dermis | 1–3 mm soft, skin-colored or yellowish papules on lower eyelids | Symmetrical eyelid distribution; soft; dermal proliferation | Micro-electrodessication; CO2 laser ablation |
| Sebaceous Hyperplasia | Hypertrophic facial oil gland surrounding central duct | 1–3 mm soft yellowish papule with central dimple (umbilication) | Central umbilication; radial "crown" vessels; oily skin context | Electrodessication; CO2 laser; low-dose isotretinoin |
| Xanthelasma | Dermal lipid-laden histiocyte (foam cell) deposits | Flat or raised yellow plaques on medial eyelids | Soft yellow velvet plaques; frequently bilateral; lipid association | Trichloroacetic acid (TCA); CO2 laser; surgical excision |
| Epidermoid Cyst | Large dermal keratin cyst from follicular infundibulum | 5–20+ mm firm subcutaneous nodule with central punctum | Movable dermal mass; foul-smelling keratin breakdown if ruptured | Complete surgical excision of intact cyst wall |
Etiology & Classification: Primary vs. Secondary Milia
Dermatologists divide milia into two main clinical categories based on anatomical tissue of origin and triggering circumstances.
CLASSIFICATION OF MILIA
MILIA
|
+-------------------------+-------------------------+
| |
PRIMARY SECONDARY
(Sebaceous Collar of Vellus Hair) (Eccrine Sweat Ducts)
| |
+------+------+ +------+------+
| | | |
Neonatal Adult Spontaneous Procedural Traumatic / Medical
(40-50%) (Eyelids/Cheeks) (CO2 Laser/ (Blisters/Steroids/
Peels) Heavy Creams)
1. Primary Milia
Primary milia develop spontaneously in undamaged skin from immature vellus hair follicle structures.
- Neonatal Milia: Present at birth in 40% to 50% of healthy full-term infants. They occur primarily on the nose, cheeks, forehead, and upper trunk. Oral mucosal variants are classified as Epstein pearls (found along the median palatal raphe in up to 85% of newborns) and Bohn nodules (found on the alveolar ridge). Neonatal milia represent temporary keratin entrapment during follicular development and clear spontaneously within 2 to 4 weeks.
- Primary Adult Milia: Spontaneous cysts occurring on the eyelids, temples, cheeks, and forehead of adults. They persist indefinitely unless physically de-roofed or exfoliated.
- Milia en Plaque (MEP): A rare clinical entity characterized by an erythematous, edematous plaque covered with dozens of tiny milia, most often located on the retroauricular area, eyelids, or submandibular cheek in middle-aged women. Histologically, MEP exhibits a dense lymphocytic dermal infiltrate surrounding multiple keratin retention cysts. Successful clearance often requires oral minocycline (100 mg daily for 4–8 weeks) combined with gentle micro-electrodessication.
2. Secondary (Traumatic or Acquired) Milia
Secondary milia arise when trauma, disease, or topical treatments disrupt the epithelium of eccrine sweat ducts or hair follicles, causing keratin retention during tissue repair.
Major causes of secondary milia include:
- Blistering Cutaneous Diseases: Epidermolysis bullosa (EB), porphyria cutanea tarda (PCT), bullous pemphigoid, and severe poison ivy (allergic contact dermatitis).
- Aesthetic & Resurfacing Procedures: Fully ablative CO2 or Er:YAG laser resurfacing, medium-to-deep TCA chemical peels, aggressive dermabrasion, and deep microneedling.
- Physical Trauma & Burns: Thermal burns, radiation therapy, and severe friction/scrapes.
- Occlusive Topical Products: Long-term application of heavy petrolatum ointments, mineral oil-based eye creams, or heavy sunscreens on occlusion-prone facial skin.
- Topical & Systemic Medications: Prolonged topical corticosteroid use (inducing epidermal atrophy), topical 5-fluorouracil (5-FU), and targeted oncologic kinase inhibitors (vemurafenib, dovitinib).
Detailed Secondary Milia Pathomechanisms
Understanding the precise cellular triggers behind secondary milia formation helps operators prevent post-procedure complications and manage drug-induced lesions.
PATHOMECHANISM OF SECONDARY (TRAUMATIC) MILIA
1. EPIDERMAL / DUCTAL TRAUMA (Laser / Blister / Burn)
|
2. DESTRUCTION OF ECCRINE SWEAT DUCT OSTIUM
|
3. EPIDERMAL REGENERATION & DUCT IMPACTION
|
4. KERATIN RETENTION ENCAPSULATION (Secondary Milium)
1. Post-Procedure Laser & Chemical Peel Traumatic Milia
During ablative CO2 laser resurfacing or deep chemical peeling, thermal energy or chemical cautery vaporizes the superficial stratum corneum and epidermis down to the papillary dermis. As re-epithelialization occurs over days 3 to 14, proliferating keratinocytes migrate over damaged eccrine sweat ducts. If a sweat duct opening becomes occluded by necrotic fibrin debris or heavy occlusive healing ointments, regenerating ductal cells trap sloughed keratin within the upper dermis, manifesting as secondary milia 3 to 6 weeks post-procedure.
2. Blistering Genodermatoses & Autoimmune Diseases
In subepidermal blistering disorders such as porphyria cutanea tarda (PCT) or epidermolysis bullosa dystrophica, micro-blisters form directly at the dermoepidermal junction or basement membrane zone. As the blister roofs collapse and re-adhere, damaged hair follicles and sweat ducts regenerate in a disorganized orientation, trapping keratin capsules beneath healed scarring tissue.
3. Drug-Induced Secondary Milia
Long-term application of high-potency topical corticosteroids induces dermal collagen degradation and epidermal atrophy. Thinning of the follicular wall allows vellus hair infundibula to collapse and form retention micro-cysts. Additionally, targeted systemic anti-cancer therapies—including BRAF inhibitors (vemurafenib) and multikinase inhibitors (dovitinib, regorafenib)—alter epidermal keratinocyte differentiation, frequently triggering widespread eruptive secondary milia across the face and upper trunk.
Neonatal Oral Mucosal Cysts: Epstein Pearls vs. Bohn Nodules
Newborn infants frequently display benign keratinaceous cysts within the oral cavity that represent anatomical variants of primary congenital milia.
| Oral Mucosal Cysts | Anatomical Location | Tissue of Origin | Incidence & Natural History | Clinical Management |
|---|---|---|---|---|
| Epstein Pearls | Median palatal raphe (junction of hard & soft palate) | Trapped epithelial remnants during palatal shelf fusion | Up to 85% of newborns; resolve spontaneously in 2–4 weeks | Reassurance only; zero treatment |
| Bohn Nodules | Buccal & lingual aspects of dental alveolar ridges | Remnants of palatal mucous gland structures | Common in newborns; shed spontaneously within weeks | Reassurance only; zero treatment |
| Dental Lamina Cysts | Crest of the alveolar ridges | Remnants of the embryonic dental lamina | Present at birth; exfoliate naturally as teeth develop | Reassurance only; zero treatment |
Parental Warning: Parents should never attempt to scrub, scrape, or wipe oral mucosal cysts in an infant. The lesions are painless and resolve naturally as the infant feeds and swallows.
Step-by-Step Clinical De-Roofing Protocol
In clinical practice, sterile manual de-roofing remains the safest, fastest, and most cost-effective method for clearing adult milia.
STERILE DE-ROOFING PROCEDURE PROTOCOL
STEP 1: ANTISEPTIC PREPARATION
Cleanse target skin with 2% chlorhexidine or 70% isopropyl alcohol.
|
STEP 2: TANGENTIAL MICRONICK
Insert 25G/30G sterile needle at 30–45° angle to create 0.5 mm epidermal nick over apex.
|
STEP 3: TANGENTIAL EXTRACTION
Apply downward & parallel pressure with sterile comedone extractor to express pearl.
|
STEP 4: POST-EXTRACTION BARRIER CARE
Apply thin layer of petrolatum or zinc-oxide ointment; restrict eye makeup for 24h.
Detailed Operator Instructions
- Equipment Assembly: Assemble a 30-gauge $1/2$-inch sterile hypodermic needle (or micro-lancet), sterile comedone extractor (curved cup or loop tip), chlorhexidine wipes, and sterile 2x2 gauze.
- Skin Stabilization: Tension the skin surrounding the milium using the non-dominant thumb and index finger.
- Apex Nick: Align the bevel of the 30G needle upward. Gently pierce the stratum corneum roof directly over the center of the milium at a 30-to-45-degree angle. The depth of the nick should be less than 0.5 mm—just enough to breach the epidermal roof without entering the vascular papillary dermis.
- Pearl Expression: Position the aperture of the comedone extractor directly over the nick. Apply steady, downward, tangential pressure. The solid white keratin pearl will pop out cleanly onto the skin surface.
- Hemostasis & Barrier: If minor pinpoint bleeding occurs, apply firm pressure with sterile gauze for 10 seconds. Apply a dab of zinc-oxide barrier cream.
Evidence-Ranked Removal Modalities
When adult milia are persistent, widespread, or located in sensitive areas, several clinical modalities offer safe removal.
1. In-Office Energy & Thermal Modalities
For widespread, recurrent, or plaque-type milia, clinicians employ focal energy devices:
- Micro-Electrodessication / Diathermy: A fine insulated epilating needle delivers low-voltage high-frequency current for a fraction of a second directly into the cyst wall. The desiccated keratin is shed automatically within 3 to 7 days.
- Ablative CO2 or Erbium:YAG Laser: A micro-spot laser beam (100–200 µm) vaporizes the overlying epidermal roof in seconds, facilitating immediate removal of keratin contents.
- Cryotherapy: Brief (1–2 second) liquid nitrogen spray. Effective on trunk lesions but generally avoided on facial skin—especially in darker skin tones—due to high rates of persistent hypopigmentation.
2. Chemical Exfoliation Kinetics & At-Home Topicals
Topical skincare products do not dissolve solid keratin pearls overnight; rather, they accelerate epidermal turnover, thinning the stratum corneum roof so the cyst eventually exfoliates out naturally over weeks.
CHEMICAL EXFOLIATION KINETICS (BHA vs. AHA)
[Salicylic Acid (BHA - Lipophilic)] [Glycolic Acid (AHA - Hydrophilic)]
- pKa: 2.97 - pKa: 3.83
- Penetrates Sebum-Rich Follicles - Exfoliates Surface Corneocytes
- Dissolves Follicular Debris - Loosens Intercellular Desmosomes
| Active Ingredient | Concentration / Strength | Biological Mechanism | Typical Timeframe | Clinical Guidance |
|---|---|---|---|---|
| Topical Adapalene | 0.1% Gel (OTC) | Normalizes follicular keratinization; accelerates epidermal desquamation | 4–8 weeks | Apply thin layer at night; excellent for preventing new facial milia |
| Prescription Tretinoin | 0.025% – 0.05% Cream | Potent RAR receptor agonist; thins stratum corneum | 3–6 weeks | Highly effective; requires barrier protection and sun precautions |
| Salicylic Acid (BHA) | 1% – 2% Lotion/Liquid | Lipophilic acid; exfoliates inside follicular infundibulum | 4–8 weeks | Best for oily skin prone to both milia and closed comedones |
| Glycolic Acid (AHA) | 5% – 10% Solution | Alpha-hydroxy acid; loosens intercellular desmosome bonds | 4–8 weeks | Ideal for dry or sun-damaged facial skin with surface milia |
For an in-depth review of how topical ingredients regulate epidermal turnover, see our skincare ingredients evidence guide.
Daily Routine Sequencing for Milia-Prone Skin
Patients prone to recurrent primary milia benefit from a structured daily regimen that optimizes epidermal turnover while preserving skin barrier function.
MILIA-PREVENTION ROUTINE SEQUENCING
[MORNING ROUTINE]
1. Gentle Non-Foaming Cleanser (pH 5.5)
2. Lightweight Hydrating Serum (Hyaluronic Acid / Niacinamide)
3. Fluid Non-Comedogenic Sunscreen (SPF 30+ Mineral Zinc Oxide)
[EVENING ROUTINE]
1. Gentle Micellar Water / Cleansing Oil (Double Cleanse)
2. Active Exfoliant / Retinoid (Alternate Nights):
- Night A: Topical Adapalene 0.1% Gel
- Night B: Salicylic Acid 2% Liquid Exfoliant
3. Non-Occlusive Gel-Cream Moisturizer (Ceramides + Fatty Acids)
Active Ingredient Compatibility Rules
- Avoid Combining Retinoids and Strong AHAs in the Same Night: Applying glycolic acid simultaneously with tretinoin or adapalene causes severe stratum corneum disruption, leading to irritant contact dermatitis without accelerating milia clearance. Alternate active nights instead.
- Barrier Protection: Always pair chemical exfoliants with non-comedogenic ceramic and cholesterol-rich moisturizers to maintain trans-epidermal water loss (TEWL) parameters.
Long-Term Recurrence Prevention & Barrier Maintenance
Patients prone to chronic primary milia formation should follow long-term maintenance protocols to prevent keratin re-entrapment:
- Non-Comedogenic Product Audit: Review all facial skincare and cosmetic products for high-occlusion ingredients (such as mineral oil, petrolatum, isopropyl myristate, or heavy lanolin). Switch periocular creams to fluid gel formulations containing hyaluronic acid and niacinamide.
- Maintenance Exfoliation Schedule: Continue low-frequency chemical exfoliation (e.g., salicylic acid 2% liquid twice weekly or adapalene 0.1% gel three nights weekly) indefinitely to maintain follicular ostium patency.
- Gentle Double Cleansing: Incorporate a gentle emulsifying oil cleanser or micellar water as step one of the evening routine to dissolve long-wearing water-resistant sunscreens without stripping epidermal barrier lipids.
DIY Warnings: The Dangers of Home Popping & Needling
Internet videos frequently demonstrate removing milia using unsterilized sewing pins, razor blades, or intense fingernail squeezing. Dermatologists strongly advise against DIY extraction due to three severe clinical complications:
- Post-Inflammatory Hyperpigmentation (PIH): Squeezing or picking at skin—especially in Fitzpatrick IV–VI skin types—triggers inflammatory cytokine release, causing melanocytes to overproduce melanin. This results in dark brown marks that can persist for 6 to 12 months.
- Permanent Atrophic Scarring: Digging below the dermoepidermal junction with a pin ruptures dermal collagen bundles, leaving permanent pitted or ice-pick scars far more disfiguring than a tiny 1 mm white bump.
- Bacterial Infection & Periorbital Cellulitis: Unsterilized tools introduce Staphylococcus aureus or Streptococcus pyogenes into the dermis. When attempted near the eyelids, bacterial invasion can progress to periorbital cellulitis requiring intravenous antibiotics.
To understand the long-term mechanics of post-trauma skin discoloration, review our analysis on why picking at the skin causes post-inflammatory hyperpigmentation.
Clinical Scenarios & Decision Algorithms
The following clinical scenarios illustrate decision-making across common patient presentations:
Scenario A: Solitary Eyelid Milium in an Adult
- Patient: 34-year-old female with a single 1.5 mm milium on the lower left eyelid.
- Action: Perform in-office sterile de-roofing using a 30G needle.
- Rationale: Self-treatment near the eye is unsafe. In-office de-roofing clears the lesion in 2 minutes without scarring.
Scenario B: Multiple Milia Post-CO2 Laser Resurfacing
- Patient: 52-year-old female presenting with 20 tiny milia across the cheeks 4 weeks after full-face ablative CO2 laser resurfacing.
- Action: Reassure patient; prescribe mild topical adapalene 0.1% gel twice weekly; perform gentle in-office extraction for larger persistent cysts at week 8.
- Rationale: Secondary milia are a temporary recovery phenomenon following re-epithelialization. Most resolve spontaneously as dermal remodeling completes.
- Learn more in our dedicated analysis of why milia can erupt after CO2 laser resurfacing.
Scenario C: Newborn Infant with Facial Milia
- Patient: 2-week-old full-term infant with numerous 1 mm white bumps across the nasal bridge.
- Action: Educate parents that lesions are congenital primary milia present in 40–50% of newborns. Advise warm water washing only; strictly forbid squeezing or applying topical products.
- Outcome: Spontaneous clearance by week 4 without intervention.
Financial Math & Insurance Status
In adult patients, milia extraction is classified as an elective cosmetic procedure.
- In-Office Manual Extraction (De-roofing): $100 – $300 per visit.
- Electrodessication or CO2 Laser Vaporization: $200 – $450 per visit.
- Prescription Topical Retinoid (Tretinoin): $40 – $90 per tube (out-of-pocket).
- Insurance Coverage: 0%. Commercial health plans do not cover milia removal because the lesions pose zero medical risk.
Frequently Asked Questions
Can I remove a milium at home with a sewing needle?
No. Home needling carries severe risks of introducing bacterial infection, puncturing blood vessels, damaging eye structures, and causing permanent pitted scars or hyperpigmentation marks. In-office sterile de-roofing takes under 5 minutes and leaves no scar.
Do topical retinoids or Differin (adapalene) get rid of milia?
Yes, gradually. OTC adapalene 0.1% or prescription tretinoin normalizes cell turnover. While they will not pop out an established cyst overnight, regular nightly use thins the overlying stratum corneum, allowing the keratin pearl to shed naturally over 4 to 8 weeks while preventing new ones.
Are milia caused by high cholesterol or a poor diet?
No. Milia are structural keratin retention cysts within hair follicles or sweat ducts. They have no relationship to dietary intake, blood lipid levels, or cholesterol. (Yellow eyelid plaques associated with high cholesterol are xanthelasma, which are histopathologically distinct).
Why do I keep getting milia under my eyes after using eye creams?
Rich, occlusive eye creams containing heavy petrolatum, mineral oil, or waxes can trap sloughed keratin inside delicate periocular hair follicles and sweat ducts. Switching to lightweight, non-comedogenic hyaluronic acid serums or gels prevents recurrent periocular milia.
What is milia en plaque and how is it treated?
Milia en plaque is a rare clinical entity where dozens of milia develop on an inflamed, erythematous plaque behind the ears, on the jawline, or on the eyelids. Treatment involves oral minocycline, topical retinoids, or micro-electrodessication administered by a dermatologist.
Sources
- StatPearls — Milia (Dragos C, Mahmood SN). NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK560481
- Medscape Drugs & Diseases — Pediatric Milia: Practice Essentials, Background, Pathophysiology. https://emedicine.medscape.com/article/910405-overview
- Cleveland Clinic — Milia Symptoms, Causes, and Clinical Management. https://my.clevelandclinic.org/health/diseases/17868-milia
- DermNet New Zealand — Milium / Milia Clinical Features & Cutaneous Cysts. https://dermnetnz.org/topics/milium
- American Academy of Dermatology (AAD) — How to Treat Milia: Public Patient Education Guidance. https://www.aad.org/public




